UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Volatility Comparison SP 500 Vs Balanced Funds Retirement analyzes how each option responds to market shocks in retirement planning.
24,544 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
UK tax authorities plan to buy crypto forensic tools to pursue digital asset tax fraud. The move signals a broader pu...
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...
Fresh data on unemployment filings show the labor market staying resilient. The big question remains whether the econ...
As regulators settle the status of digital assets and major networks scale, XRP and Solana remain top bets for a long...
Baozun's baozun (bzun) 2025 earnings signal shifts in China’s DTC ecosystem. This article breaks down Q4 results, mar...
Policymakers are weighing tax shifts that could touch luxury spending by the ultra-wealthy. Investors watch designer ...
Hyped up rare-earth plays attract attention, but many stumble before they mine. This guide breaks down how to assess ...
This article breaks down what to expect from the NESR 2026 earnings call, including key revenue drivers, profitabilit...
Greg Abel is quietly rebalancing Berkshire Hathaway’s equity book, moving away from U.S. financials and toward intern...
Explore dragonfly (dfli) 2026 earnings to understand growth drivers, margin discipline, and what the results imply fo...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...